GMP Software: Quality Management for Good Manufacturing Practice Compliance

All seven GMP pillars. One validated platform.

GMP Software: A Single Validated Platform for Every Regulated Industry That Operates Under Good Manufacturing Practice

GMP software is a quality management system built to manage the documentation, training, investigation, and record-keeping requirements that Good Manufacturing Practice regulations impose on manufacturers across regulated industries. The term GMP — Good Manufacturing Practice — applies to a wider range of industries than pharmaceutical manufacturing alone. Pharmaceutical manufacturers operate under FDA’s Current Good Manufacturing Practice regulations in 21 CFR Parts 210 and 211. Food and beverage manufacturers operate under 21 CFR Parts 110 and 117. Dietary supplement manufacturers operate under 21 CFR Part 111. Biotechnology and CDMO/CRO organizations operate under drug GMP requirements and, where applicable, biologics manufacturing standards. Cannabis and hemp manufacturers operate under state-level cGMP frameworks that increasingly reference federal drug GMP standards. Medical device manufacturers operate under production and quality controls in the QMSR and ISO 13485 that parallel GMP requirements in structure and intent.

What these frameworks share is more significant than what separates them: trained and qualified personnel, controlled documentation, validated or verified processes, complete and retrievable records, investigated deviations and nonconformances, and a corrective action system that closes quality loops and prevents recurrence. GMP software that is purpose-built for regulated manufacturing must address all of those requirements — not as generic quality management features but as compliance architecture configured for the specific regulatory framework the manufacturer operates under.

eLeaP is a GMP software platform because it manages GMP-required quality processes across all of those industries in a single validated system. The core differentiator is native QMS and LMS integration: when a procedure is revised, training assignments generate automatically for every affected role; when a CAPA is initiated, training can be triggered as part of the corrective action; when a design change or process change takes effect, the training gate prevents record closure until completion is confirmed. This page covers what GMP requires across the industries it governs, how eLeaP addresses those requirements, and how to evaluate GMP software for your specific regulatory context.

GMP vs. cGMP: What the Distinction Means for Software Selection

Good Manufacturing Practice establishes the baseline quality system requirements for manufacturing in regulated industries. Current Good Manufacturing Practice is the FDA’s regulatory term, and the ‘c’ reflects FDA’s position that compliance must reflect the current state of manufacturing technology and quality system practice — not just the standards in place when the regulation was first promulgated. FDA regularly issues guidance documents, warning letters, and inspection program updates that advance what current practice means for specific GMP areas.

For software selection, the cGMP standard has concrete implications. An electronic batch record system that does not enforce real-time exception capture and data integrity controls does not meet current practice expectations. A CAPA system that cannot enforce effectiveness verification before closure does not meet current practice. A training system that cannot link completion records to specific document versions — demonstrating that personnel are trained on the current version, not a superseded one — does not meet current practice. FDA’s increasing emphasis on data integrity, audit trail completeness, and computerized system validation in inspection programs reflects the current standard moving continuously toward more rigorous electronic quality system requirements.

The same principle applies across GMP frameworks. FDA’s Food Safety Modernization Act (FSMA) updated food manufacturing GMP requirements precisely because prior standards did not reflect current science on preventive controls. State cannabis regulators are converging on drug GMP frameworks rather than food GMP frameworks because drug GMP provides the more rigorous current standard. A GMP software platform must be designed against the current standard in each applicable framework — not the baseline from a prior decade.

GMP Requirements by Industry: What Each Framework Requires and Where to Find Vertical Depth

GMP applies differently across regulated industries in terms of specific citations, documentation requirements, and inspection frameworks. The sections below cover the governing framework for each industry, the core GMP obligations, and the eLeaP vertical page where full regulatory depth is covered.

Pharmaceutical Manufacturing — 21 CFR Parts 210 and 211

Pharmaceutical manufacturers producing finished drug products for FDA-regulated markets operate under 21 CFR Parts 210 and 211 — the cGMP regulations for finished pharmaceuticals. The core obligations cover seven compliance pillars: trained and qualified personnel (21 CFR Part 211.25), qualified facilities and equipment (21 CFR Parts 211.63 and 211.68), validated processes (21 CFR Part 211.100 and FDA’s 2011 process validation guidance), controlled documentation (21 CFR Parts 211.100 and 211.186), complete and retrievable batch records (21 CFR Parts 211.188 and 211.192), investigated out-of-specification test results (21 CFR Part 211.192 and FDA’s OOS guidance), and investigated complaints (21 CFR Part 211.198). Electronic records and signatures used in drug GMP manufacturing must comply with 21 CFR Part 11. ICH Q10 provides the pharmaceutical quality system framework that FDA expects manufacturers to implement, with CAPA requirements at Section 3.2.2 and change management at Section 3.2.3.

Pharmaceutical manufacturing is the most inspection-intensive GMP context, with FDA’s Office of Pharmaceutical Quality conducting pre-approval inspections, surveillance inspections, and for-cause inspections under a risk-based site selection framework. Training record deficiencies — records that reference superseded procedure versions, or roles that were not updated when personnel responsibilities changed — are among the most common sources of 483 observations. The integration between document control and training management is the architectural requirement that distinguishes a pharmaceutical GMP compliance system from a generic QMS.

Food and Beverage Manufacturing — 21 CFR Parts 117 and 111

Food and beverage manufacturers operating under FDA jurisdiction are subject to the Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food regulation — 21 CFR Part 117 — established under the Food Safety Modernization Act. Part 117 requires written food safety plans, hazard analyses, preventive controls, monitoring procedures, corrective action procedures, and verification records. Personnel training requirements under Part 117 mandate that food safety personnel are qualified through training or experience, and that Preventive Controls Qualified Individuals (PCQIs) receive specific training in the application of risk-based preventive controls. Dietary supplement manufacturers are subject to 21 CFR Part 111, which requires master manufacturing records, batch production records, and personnel training documentation that parallels drug GMP in structure.

Food GMP under FSMA places particular emphasis on hazard analysis and preventive controls — the HACCP-based framework that replaces the prior reactive approach to food safety. GMP software for food manufacturing must manage food safety plan documentation, preventive control monitoring records, and the corrective action and verification activities that FSMA requires when a preventive control is not properly implemented. The training gate that links procedure revisions to automatic training assignment generation is especially important in food manufacturing, where sanitation procedures, allergen control procedures, and environmental monitoring procedures are revised frequently and must be followed consistently by production and quality personnel.

Biotechnology and CDMO/CRO — 21 CFR Parts 210/211 and Biologics GMP

Biotechnology manufacturers producing drug products — including biologics, cell and gene therapies, and combination products — operate under drug GMP requirements in 21 CFR Parts 210 and 211, with additional requirements for biological products under 21 CFR Part 600-series regulations where applicable. CDMOs and CROs operating under GMP conditions as contract manufacturers or clinical trial service providers are subject to the same drug GMP framework as their sponsor clients, with the additional obligation to manage multi-client quality agreements and client-specific quality oversight requirements. ICH Q10 and ICH Q7 (GMP for active pharmaceutical ingredients) provide the quality system and GMP framework that biotech and CDMO organizations apply alongside the CFR requirements.

The complexity of biotech GMP compliance lies partly in the scope of change control: a change to a manufacturing process at a CDMO may trigger quality agreement notifications to multiple sponsor clients, each with their own change control evaluation requirements. GMP software for biotech and CDMO contexts must support multi-product record architecture, client quality agreement tracking, and the training gate that applies to process changes affecting personnel across multiple product lines.

Cannabis and Hemp Manufacturing — State cGMP Frameworks

Licensed cannabis and hemp manufacturers operate under state regulatory frameworks that vary by jurisdiction but are converging on cGMP manufacturing standards derived from FDA’s drug GMP framework. Several states require licensed cannabis processors and manufacturers to operate under documented quality management systems that include written SOPs, batch production records, personnel training records, deviation management, and CAPA. As the cannabis regulatory landscape matures, the expectation that licensed manufacturers demonstrate GMP-equivalent quality system controls is increasingly embedded in state licensing requirements and third-party certification schemes.

Cannabis and hemp GMP software must manage batch production records, SOP version control, personnel training documentation, and the CAPA system that state regulators examine during inspections. The training gate that applies to SOP revisions is particularly important in cannabis manufacturing, where high employee turnover and rapid product portfolio expansion create ongoing training compliance risk. Multi-state operators managing quality systems across licensed facilities in different regulatory jurisdictions benefit from a single QMS platform that maintains consistent quality system architecture while accommodating jurisdiction-specific documentation requirements.

Medical Device Manufacturing — QMSR and ISO 13485 Production Controls

Medical device manufacturers operating under FDA jurisdiction are subject to the Quality Management System Regulation (QMSR), effective February 2, 2026, which incorporates ISO 13485:2016 by reference as its base quality management framework. The QMSR does not use the term GMP in the same way that drug regulations do, but its production and process control requirements — ISO 13485 Section 7.5 — are GMP-equivalent in intent: controlled production processes, qualified equipment, inspection and testing at defined stages, traceability of product to materials and processes, and preservation of product through production and delivery. The QMSR and ISO 13485 additionally require design controls (Section 7.3), risk management integration (ISO 14971), and a design history file that connects design outputs to production specifications.

Medical device GMP software must integrate design controls with production quality, CAPA with design change management, and training management with both document control and design-change-driven procedure revisions. The training gate that gates design change closure on confirmed training completion is the production-phase equivalent of the drug GMP training requirement for procedure version currency — different regulatory language, same compliance logic.

The Seven GMP Compliance Pillars: Cross-Vertical Requirements and How eLeaP Addresses Each

Across all GMP frameworks — drug, food, biotech, cannabis, and medical device production controls — seven operational pillars define what a GMP quality system must manage. The regulatory citation differs by industry; the compliance logic is consistent. The table below shows the cross-vertical citation structure. The sections that follow cover what each pillar requires and how eLeaP addresses it.

Pillar 1 — Trained and Qualified Personnel: Pharma: 21 CFR Part 211.25 | Food: 21 CFR Part 117.4 | Dietary Supplements: 21 CFR Part 111.12 | Medical Device: ISO 13485 Section 6.2 / QMSR

Pillar 2 — Qualified Facilities and Equipment: Pharma: 21 CFR Parts 211.63 and 211.68 | Food: 21 CFR Part 117.40 | Medical Device: ISO 13485 Section 7.5.1

Pillar 3 — Validated/Verified Processes: Pharma: 21 CFR Part 211.100, FDA 2011 Process Validation Guidance | Food: 21 CFR Part 117.160 (verification activities) | Medical Device: ISO 13485 Section 7.5.6

Pillar 4 — Controlled Documentation: Pharma: 21 CFR Parts 211.100 and 211.186 | Food: 21 CFR Part 117.315 | Medical Device: ISO 13485 Section 4.2.4

Pillar 5 — Complete and Retrievable Records: Pharma: 21 CFR Parts 211.188 and 211.192 | Food: 21 CFR Part 117.190 | Medical Device: ISO 13485 Section 4.2.5

Pillar 6 — Investigated Deviations and Nonconformances: Pharma: 21 CFR Part 211.192 (OOS) | Food: 21 CFR Part 117.150 (corrective actions) | Medical Device: ISO 13485 Section 8.3

Pillar 7 — Investigated Complaints: Pharma: 21 CFR Part 211.198 | Food: 21 CFR Part 117.150 | Medical Device: ISO 13485 Section 8.2.2

Pillar 1: Trained and Qualified Personnel

Every GMP framework requires that personnel performing regulated manufacturing activities have the qualifications — through education, training, experience, or a combination — to execute their assigned functions competently. Training must be documented. The specific citation varies: 21 CFR Part 211.25 for pharmaceutical personnel, 21 CFR Part 117.4 for food safety personnel, ISO 13485 Section 6.2 for medical device personnel. The compliance failure mode is consistent across all frameworks: personnel working under a procedure version that has been superseded by a revision they have not been trained on.

eLeaP addresses this pillar through the integrated LMS. The training matrix defines required training by role. When any procedure reaches effective status following a revision, eLeaP automatically generates retraining assignments for every role assigned to that procedure. Completion records carry the specific document version number. The training gap that generates the most common GMP observation across all regulated industries — operators or analysts working under superseded procedures — is closed at the system architecture level rather than managed through manual tracking.

Pillar 2: Qualified Facilities and Equipment

GMP regulations across all frameworks require that facilities and equipment be designed, constructed, and maintained to support the manufacturing activities they are used for. Equipment qualification — Installation Qualification, Operational Qualification, and Performance Qualification — is the documented evidence that specific equipment is suitable for its intended GMP use. Calibration programs must be documented and followed. Changes to equipment or facilities that affect qualified or validated states require change control assessment and, where affected, requalification.

eLeaP manages equipment qualification and calibration records linked to the equipment record within the quality system. IQ, OQ, and PQ protocols and reports link to the equipment record. Requalification triggers — scheduled interval, change control event, or deviation event involving the equipment — generate tasks within the system. Equipment out of calibration or with an expired qualification interval generates a status flag that prevents the equipment from being selected or logged in electronic batch or production records until the qualification or calibration is renewed and documented.

Pillar 3: Validated and Verified Processes

GMP regulations require that manufacturing processes be validated or verified to demonstrate they consistently produce output meeting defined specifications. For pharmaceutical manufacturers, FDA’s 2011 process validation guidance defines a three-stage lifecycle: Stage 1 process design, Stage 2 process qualification, and Stage 3 continued process verification. For food manufacturers under FSMA, verification activities under 21 CFR Part 117.160 confirm that preventive controls are consistently implemented and effective. For medical device manufacturers, ISO 13485 Section 7.5.6 requires validation of processes where the resulting output cannot be verified by subsequent monitoring or measurement.

eLeaP manages process validation and verification documentation within the product or process record structure. Validation and verification protocols and reports for each stage or activity link to the process they cover. Changes to validated or verified processes route through the change control workflow, which includes a validated state impact assessment and generates revalidation or re-verification requirements where the assessment indicates the change affects the validated state.

Pillar 4: Controlled Documentation

GMP documentation control requires that current procedures be accessible to the personnel performing the activities they govern, that prior versions be archived but not accessible as current, and that document changes be reviewed, approved, and implemented through a controlled process. The specific requirements vary by framework — master production records under 21 CFR Part 211.186 for pharmaceuticals, food safety plan documentation under 21 CFR Part 117 for food manufacturers, quality management system documentation under ISO 13485 Section 4.2.4 for medical device manufacturers — but the compliance logic is the same: personnel must work from current, approved documents.

eLeaP’s document control module manages the full procedure and record lifecycle with 21 CFR Part 11-compliant electronic signatures on authoring, review, and approval. The effective date triggers automatic supersession of the prior version and automatic distribution to authorized roles. Personnel cannot access a superseded version through the active document library once a new version is effective. When a document is approved and reaches effective status, the integrated LMS generates training assignments for every role assigned to that document — closing the interval between procedure approval and workforce training.

Pillar 5: Complete and Retrievable Records

GMP regulations across all frameworks require that production and quality records be complete, accurate, and readily retrievable for regulatory review. For pharmaceutical manufacturers, batch production and control records under 21 CFR Part 211.188 must document every production step. For food manufacturers, records required under 21 CFR Part 117.190 must be retained for defined periods and be available for FDA review. For medical device manufacturers, the medical device file under ISO 13485 Section 4.2.5 must contain or reference the records that demonstrate the device was produced in accordance with its design and production specifications.

eLeaP captures production and quality records with operator identity, server-generated timestamps, in-process results, and deviation records linked directly from within the production record. Data integrity under GMP requires more than structured capture — it requires unalterable audit trails that satisfy ALCOA+ principles: Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, and Available. eLeaP enforces ALCOA+ through system-generated audit trails that record the identity of each user, the exact value entered, the timestamp, and any subsequent change — including the original value, the revised value, the person making the change, and the documented reason. Records are indexed and retrievable by product, batch or lot number, and date without requiring custom data exports.

Pillar 6: Investigated Deviations and Nonconformances

GMP regulations require that deviations from specifications and established procedures be investigated, root causes identified, and corrective actions implemented where systemic causes are found. For pharmaceutical manufacturers, the OOS investigation framework under 21 CFR Part 211.192 and FDA’s OOS guidance specifies a two-phase investigation structure. For food manufacturers under FSMA, corrective action and corrective action verification procedures under 21 CFR Part 117.150 address preventive control failures. For medical device manufacturers, ISO 13485 Section 8.3 governs control of nonconforming product.

eLeaP’s quality event management system enforces the investigation structure required by each applicable framework. For pharmaceutical OOS investigations, the two-phase structure is enforced: Phase 1 laboratory investigation must be completed and documented before Phase 2 can be initiated, and Phase 2 records connect to the batch record for the affected lot and to CAPA where a systemic cause is identified. Batch record exception flags automatically prompt the generation of a deviation workflow within the quality system. Investigation trends are available for management review without manual data compilation.

Pillar 7: Investigated Complaints

GMP regulations across all frameworks require that complaints — from customers, consumers, healthcare professionals, or regulators — be documented, investigated where required, and addressed through the quality system. For pharmaceutical manufacturers, 21 CFR Part 211.198 requires investigation of every complaint involving a possible specification failure and evaluation of whether other lots are affected. For medical device manufacturers, ISO 13485 Section 8.2.2 requires procedures for receiving and investigating feedback and complaints. For food manufacturers, complaint handling connects to the FSMA corrective action framework when complaints indicate a potential food safety issue.

eLeaP’s complaint management module captures complaints with the required intake fields for each applicable framework and routes them to the quality unit for investigation determination. Lot or batch extension evaluation — whether the complaint indicates a quality failure affecting other distributed product — is a required workflow stage for complaints involving possible product defects. CAPA is initiated directly from within the complaint investigation record when the investigation confirms a quality system failure. Complaint trending surfaces patterns by product, lot family, and complaint type for proactive quality management and management review reporting.

GMP Training Management: The Cross-Vertical Requirement That Connects the Quality System to the Workforce

Across every GMP framework — pharmaceutical, food, biotech, cannabis, and medical device production controls — the training management requirement has the same core structure: personnel must be qualified to perform their assigned functions, and when procedures change, the workforce must be trained on the current version before the change is considered effectively implemented. The regulatory citation differs by industry. The compliance failure mode is consistent: an inspector asks whether personnel are trained on the current version of a procedure, and the answer requires manual reconciliation between training records and document version history.

eLeaP’s integrated QMS and LMS eliminates that reconciliation requirement. Every procedure revision that reaches effective status in the document control system automatically generates training assignments for all affected roles. The assignment carries the document version number. The completion record links to that specific version. No manual action is required between a procedure being approved and the training assignments being created. The training gate prevents document implementation or associated quality event closure until all required completions are confirmed — making version-current training demonstrable from the system without manual cross-referencing.

This architecture addresses the most common training-related observation finding across all GMP-regulated industries: the interval between a procedure revision becoming effective and the workforce being trained on it. In a manufacturing facility revising dozens of procedures per year across multiple product lines, managing that interval manually produces gaps proportional to revision volume and workforce size. eLeaP closes that gap structurally.

Evaluating GMP Software: Five Questions That Apply Across Every Regulated Industry

GMP software evaluation should test compliance architecture, not feature presence. The five questions below are framework-agnostic — they apply equally to pharmaceutical, food, biotech, cannabis, and medical device buyers evaluating whether a platform is a genuine compliance system or a documentation tool with compliance features added.

Question 1: Does a Procedure Revision Automatically Generate Version-Current Training Assignments?

Does a procedure revision automatically generate training assignments for all affected roles with the document version captured in the completion record — so that version-current training is demonstrable from the system without manual reconciliation? This is the single most consequential architectural question for GMP training compliance across all regulated industries. If the answer requires manual steps between document approval and training assignment creation, the system produces gaps proportional to revision volume.

Question 2: Does the Deviation Investigation Workflow Enforce the Required Investigation Structure?

Does the deviation or nonconformance investigation workflow enforce the investigation structure required by the applicable GMP framework — for pharmaceutical OOS, the two-phase FDA guidance structure; for food manufacturers, the FSMA corrective action and verification sequence; for medical device manufacturers, the ISO 13485 nonconforming product procedure? A system that allows an investigation to be closed without completing required phases, or that does not require lot or batch extension evaluation, does not enforce the regulatory requirement.

Question 3: Does the Production Record System Capture Data with Audit Trail Integrity?

Does the production or batch record system capture each execution entry with operator identity, server-generated timestamp, and entered values — and enforce ALCOA+ data integrity principles through an unalterable system-generated audit trail? FDA’s data integrity expectations apply across pharmaceutical, food, and medical device GMP frameworks. A system that allows records to be modified without a documented audit trail does not meet current GMP expectations regardless of which framework applies.

Question 4: Does the CAPA Workflow Gate Closure on Documented Effectiveness Verification?

Does the CAPA workflow require effectiveness verification criteria to be defined before corrective action implementation, and prevent CAPA closure without a completed effectiveness verification sign-off? This requirement appears across GMP frameworks: ICH Q10 Section 3.2.2 for pharmaceutical CAPA, FSMA corrective action verification under 21 CFR Part 117.150 for food manufacturers, and ISO 13485 Section 8.5.2 for medical device CAPA. A CAPA system that can be closed without documented effectiveness verification is an open compliance risk in any GMP context.

Question 5: Does the Platform Provide a Validation Support Package?

Does the platform provide a validation support package — IQ, OQ, and PQ protocols with traceability to 21 CFR Part 11 requirements, advance notification of system changes, and impact assessment documentation for the customer’s change control evaluation? GMP software is itself a computerized system subject to validation requirements under the applicable GMP framework. The validation support package is part of the compliance infrastructure the platform must provide, not an optional service.

eLeaP’s answers to all five questions are yes. The GMP software demonstration is configured for the buyer’s industry and regulatory context — pharmaceutical batch records and OOS investigations, FSMA food safety plan documentation, medical device DHF and production records, or cannabis batch production and state compliance. Request a scoped GMP software demonstration at eleapsoftware.com.

Frequently Asked Questions: GMP Software

What is GMP software?

GMP software is a quality management system built to manage the documentation, workflow, investigation, and training requirements that Good Manufacturing Practice regulations impose on regulated manufacturers. GMP regulations apply across pharmaceutical manufacturing (21 CFR Parts 210/211), food and beverage manufacturing (21 CFR Parts 110/117), dietary supplement manufacturing (21 CFR Part 111), biotechnology (21 CFR Parts 210/211 and biologics regulations), cannabis and hemp manufacturing (state cGMP frameworks), and medical device manufacturing (QMSR and ISO 13485 production controls). GMP software that is purpose-built for regulated manufacturing enforces the specific workflow sequences and documentation standards that each framework requires — not generic quality management workflows with GMP terminology applied.

Does GMP apply to industries other than pharmaceutical manufacturing?

Yes. Good Manufacturing Practice requirements apply to pharmaceutical manufacturers, food and beverage manufacturers, dietary supplement manufacturers, biotechnology and CDMO/CRO organizations, cannabis and hemp manufacturers, and — under equivalent production control frameworks — medical device manufacturers. The regulatory citations differ: 21 CFR Parts 210 and 211 for drug products, 21 CFR Part 117 for human food, 21 CFR Part 111 for dietary supplements, state cGMP frameworks for cannabis, and QMSR/ISO 13485 for medical devices. The core compliance logic — trained personnel, controlled documentation, validated or verified processes, complete records, investigated deviations, and investigated complaints — is consistent across all frameworks.

What is the difference between GMP and cGMP?

GMP (Good Manufacturing Practice) is the foundational quality system standard for regulated manufacturing. cGMP (Current Good Manufacturing Practice) is FDA’s regulatory term, where the ‘c’ reflects FDA’s position that compliance must reflect the current state of manufacturing technology and quality system practice. FDA advances what current practice means through guidance documents, warning letters, and inspection programs over time — so a system that met cGMP expectations a decade ago may not meet current expectations today. For software selection, a cGMP-compliant system must support current FDA expectations around data integrity, electronic records, audit trail completeness, and computerized system validation.

What are the seven GMP compliance pillars?

The seven GMP compliance pillars — derived from the operational requirements common across pharmaceutical, food, biotech, and medical device GMP frameworks — are: (1) trained and qualified personnel; (2) qualified facilities and equipment; (3) validated or verified processes; (4) controlled documentation; (5) complete and retrievable production and quality records; (6) investigated deviations and nonconformances; and (7) investigated complaints. The regulatory citations for each pillar differ by industry, but every GMP-regulated manufacturer must demonstrate compliance with all seven. A GMP software platform that addresses fewer than all seven requires supplementation with additional systems or manual processes.

What is the training gate mechanism and why is it important for GMP compliance?

The training gate mechanism prevents record closure — such as document implementation, CAPA closure, or change control completion — until all required training completions for affected personnel roles are confirmed. In GMP manufacturing, a procedure revision is not effectively implemented until the workforce working under that procedure has been trained on the current version. The training gate enforces that requirement at the system level: when a revised document reaches effective status, the integrated LMS generates training assignments for all affected roles, and the quality record cannot advance to closed status until those assignments are confirmed complete. This eliminates the interval between procedure approval and workforce training — the gap that generates the most common training-related GMP observation findings across all regulated industries.

How does GMP software for food manufacturers differ from pharmaceutical GMP software?

Food GMP software under FSMA (21 CFR Part 117) addresses hazard analysis, preventive controls, monitoring records, corrective action procedures, and verification activities — a risk-based framework centered on preventing food safety hazards rather than investigating specification failures after the fact. Pharmaceutical GMP software under 21 CFR Parts 210 and 211 addresses batch production records, OOS investigation procedures, and a specification-compliance framework where every batch must be tested and released against defined specifications. The training requirements, document control requirements, CAPA architecture, and audit trail expectations are structurally similar across both frameworks. A GMP software platform that supports both industries in a single system must configure the framework-specific workflows — OOS investigations for pharma, FSMA corrective action and verification for food — within a common quality record architecture.

What is ALCOA+ and why does it matter for GMP software?

ALCOA+ is the data integrity standard that GMP regulations expect electronic records to meet: Attributable (each entry identifies the person who made it), Legible (records are readable and permanent), Contemporaneous (records are made at the time the activity occurs), Original (records are the first capture of data, not transcriptions), and Accurate (records reflect what actually occurred) — plus Complete, Consistent, Enduring, and Available. FDA’s data integrity guidance applies ALCOA+ expectations to electronic GMP records across pharmaceutical, food, and medical device frameworks. GMP software must enforce ALCOA+ through system-generated, unalterable audit trails that capture the identity of each user, the value entered, the timestamp, and any subsequent change with its reason — without the ability to overwrite or delete records outside the audit trail.

Does GMP software need to be validated?

Yes. GMP software is a computerized system used in regulated manufacturing and is subject to computerized system validation requirements under the applicable GMP framework: 21 CFR Part 211.68 and 21 CFR Part 11 for pharmaceutical and food manufacturers, ISO 13485 Section 4.1.6 and applicable GAMP 5 guidance for medical device manufacturers. Validation demonstrates that the system consistently performs its intended functions in a documented and reproducible manner. The validation package includes IQ, OQ, and PQ protocols and reports, ongoing change control to maintain the validated state, and periodic review. Manufacturers validate the software in their specific use environment using a vendor-provided validation support package as the baseline documentation.

Can one GMP software platform serve multiple regulated industries?

Yes — when the platform’s architecture separates the common quality system infrastructure from the industry-specific workflow configurations. The common infrastructure — document control, training management, CAPA, change control, audit trail — is the same across pharmaceutical, food, biotech, cannabis, and medical device GMP requirements. The industry-specific configurations are the workflow enforcement rules and record structures that reflect each framework: OOS investigation phases for pharma, FSMA preventive control monitoring records for food, design history file structure for medical devices. eLeaP serves all of those industries in a single validated platform by maintaining the common infrastructure while configuring the framework-specific workflows for each customer’s regulatory context.

GMP Software: Terminology and Search Synonyms

GMP software is referenced by several terms across regulatory guidance, industry publications, and quality management software categories. The following synonyms and related terms describe the capabilities covered on this page or on linked vertical pages.

cGMP Compliance Software / cGMP Quality Management Software

‘cGMP compliance software’ and ‘cGMP quality management software’ are the most direct synonyms for GMP software in the pharmaceutical and regulated manufacturing context. The cGMP framing emphasizes FDA’s current practice standard. All seven GMP pillars covered on this page fall within the cGMP compliance software category, applicable across pharmaceutical, food, biotech, and cannabis manufacturing.

Pharmaceutical GMP Software / Drug GMP Software

‘Pharmaceutical GMP software’ and ‘drug GMP software’ refer specifically to GMP software configured for 21 CFR Parts 210 and 211 compliance — the pharmaceutical-specific pillar treatment, OOS investigation workflow, batch record system, and complaint investigation procedures covered in depth at the pharmaceutical QMS vertical page.

Food GMP Software / FSMA Compliance Software

‘Food GMP software’ and ‘FSMA compliance software’ refer to GMP software configured for 21 CFR Part 117 compliance — food safety plan documentation, hazard analysis records, preventive control monitoring, FSMA corrective action and verification workflows, and PCQI training management. Covered in depth at the food and beverage QMS vertical page.

Biotech GMP Software / GxP Quality Management Software

‘Biotech GMP software’ and ‘GxP quality management software’ refer to GMP software configured for biotechnology and CDMO/CRO organizations operating under drug GMP and biologics GMP requirements. GxP as a category term encompasses GMP, GLP (Good Laboratory Practice), and GCP (Good Clinical Practice) — all of which share common quality system infrastructure requirements. Covered in depth at the biotechnology QMS vertical page.

Cannabis GMP Software / Cannabis Quality Management Software

‘Cannabis GMP software’ and ‘cannabis quality management software’ refer to GMP software configured for licensed cannabis and hemp manufacturers operating under state cGMP frameworks. The documentation requirements — SOPs, batch production records, personnel training, CAPA, deviation management — parallel drug GMP in structure. Covered in depth at the cannabis and hemp QMS vertical page.

Medical Device GMP Software / Production Quality Software

‘Medical device GMP software’ and ‘production quality software’ refer to the production-phase quality management capability for medical device manufacturers under QMSR and ISO 13485 — the GMP-equivalent production controls in Section 7.5, along with design controls, DHF management, and design-change-driven training. Covered in depth at the medical device QMS vertical page.

Validated QMS / Validated GMP Software

‘Validated QMS’ and ‘validated GMP software’ refer to a quality management platform that has been subject to computerized system validation — IQ, OQ, and PQ — demonstrating it consistently performs its intended functions. For GMP manufacturers, software validation is a regulatory requirement, not a vendor differentiator. The validation support package that eLeaP provides gives customers the baseline IQ, OQ, and PQ documentation to which site-specific validation evidence is added.

About eLeaP QMS

eLeaP is a quality management and learning management platform built by Telania, LLC, founded in 2002. The platform serves regulated-industry manufacturers across pharmaceutical, medical device, biotech, CDMO/CRO, food and beverage, cannabis, and aerospace — industries that require a fully integrated QMS and LMS in a single validated system. The core differentiator is native QMS+LMS integration: procedure revisions automatically trigger training assignments, CAPA-triggered training enforces corrective action effectiveness, and the training gate mechanism prevents record closure until training completions are confirmed. eLeaP is designed for mid-market manufacturers (50–500 employees) who require full GMP compliance capability without enterprise implementation complexity or cost.

Related resources: